A drug that once helped obese adults lose weight, withdrawn from the market due to heart risks, may be safe and effective for children with a seizure disorder called Dravet syndrome, say researchers. The drug fenfluramine was developed for pediatric use and found to decrease the number of seizures by more than half for many Dravet syndrome patients.